- Home
- ITRG vs XOMA Comparison
ITRG vs XOMA Comparison
Compare ITRG & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | XOMA |
|---|---|---|
| Founded | 1997 | 1981 |
| Country | Canada | United States |
| Employees | N/A | 14 |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 572.1M | 471.6M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ITRG | XOMA |
|---|---|---|
| Price | $2.62 | $41.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $5.13 | ★ $52.50 |
| AVG Volume (30 Days) | ★ 3.2M | 91.2K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $67.34 | $24.59 |
| Revenue Next Year | $25.89 | N/A |
| P/E Ratio | $45.07 | ★ $29.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.43 | $22.29 |
| 52 Week High | $4.87 | $42.81 |
Technical Indicators
Market Signals| Indicator | ITRG | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 50.30 | 59.80 |
| Support Level | $2.60 | $37.00 |
| Resistance Level | $2.80 | $42.25 |
| Average True Range (ATR) | 0.15 | 0.36 |
| MACD | 0.04 | -0.16 |
| Stochastic Oscillator | 54.07 | 48.48 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.